Healthcare AI

Twitter

Facebook

Copy Link

Key Facts

Key PlayersTempus, Viz.ai, Nuance

AI AdoptionGrowing

Use CasesMedical Imaging, Clinical Decision Support, Patient Triage

Top News

xAI and SpaceX hit with class-action lawsuit over data center noise and pollution impacts

Mississippi residents filed a class-action lawsuit against xAI and SpaceX, claiming gas-fired power plants for data centers create 'omnipresent and inescapable' noise around the clock. The suit estimates over 10,000 affected residents and seeks damages for health impacts and lost property values. It's the latest escalation in mounting community backlash against AI infrastructure expansion across the United States.

Policy2 sources

xAI and SpaceX hit with class-action lawsuit over data center noise and pollution impacts

Policy2 sources

AI Dolls Provide Elderly Care in South Korea as Loneliness Crisis Deepens

South Korea is deploying AI-powered companion dolls to care for elderly individuals living alone as the country battles a loneliness epidemic. With over 3,920 lonely deaths recorded in 2024 and 42 percent of households being single-person, municipalities are providing devices like Hyodol to offer emotional support, medication reminders, and daily companionship to vulnerable seniors.

Entertainment2 sources

AI Dolls Provide Elderly Care in South Korea as Loneliness Crisis Deepens

Entertainment2 sources

Hetairos AI classifies brain tumors in 12 minutes with 87% accuracy, outperforming specialists

Researchers at the German Cancer Research Center have developed Hetairos, an AI system that identifies over 100 molecular subtypes of brain tumors using standard microscopic tissue sections. Trained on more than 11,000 slides from 9,606 patients across four continents, the system delivers diagnoses in 12 minutes with 87% accuracy—significantly outperforming experienced neuropathologists in head-to-head testing.

Science2 sources

Hetairos AI classifies brain tumors in 12 minutes with 87% accuracy, outperforming specialists

Science2 sources

Machine learning model plasmaCHORD filters biological noise to improve liquid biopsy accuracy

Researchers at Johns Hopkins Kimmel Cancer Center developed plasmaCHORD, a machine learning model that distinguishes tumor mutations from white blood cell mutations in liquid biopsy samples. The model improved accuracy from approximately 50% to 83% for clinically relevant mutations, helping clinicians select more effective targeted cancer treatments and avoid therapies unlikely to work.

Health2 sources

Machine learning model plasmaCHORD filters biological noise to improve liquid biopsy accuracy

Health2 sources

Common joint supplement glucosamine linked to 25% faster Alzheimer's progression in new study

University of Florida researchers discovered that glucosamine, a widely used over-the-counter joint supplement, is associated with a 25% higher likelihood of progressing from mild cognitive impairment to Alzheimer's disease. The study analyzed 12 years of health records and found the supplement may worsen disease progression in millions of seniors who take it for joint pain.

Health2 sources

Common joint supplement glucosamine linked to 25% faster Alzheimer's progression in new study

Health2 sources

AI screening tool boosts diabetic eye exam referrals for African Americans by 46%

Johns Hopkins researchers found that African American patients with diabetes were significantly more likely to receive diabetic eye exam referrals when screened with an FDA-approved AI tool compared to traditional primary care provider referrals. The AI-assisted diagnostic tool analyzed retinal images in real time, providing immediate results that increased patient adherence to essential screenings for diabetic retinopathy.

Health2 sources

AI screening tool boosts diabetic eye exam referrals for African Americans by 46%

Health2 sources

NHS Doctors Face Legal Risk as AI Liability Gap Leaves Them Exposed to Negligence Claims

The Medical Protection Society warns that doctors and the NHS could become liable for medical errors made by AI tools under outdated UK law. With AI increasingly used for diagnoses and treatment recommendations, the organization calls for urgent legal reform to classify AI systems as products and ensure accountability for AI errors is shared with developers and manufacturers.

Policy2 sources

NHS Doctors Face Legal Risk as AI Liability Gap Leaves Them Exposed to Negligence Claims

Policy2 sources

NHS England deploys Microsoft Copilot to 505,000 staff in largest healthcare AI rollout

NHS England is rolling out Microsoft Copilot to over 505,000 clinicians and support staff following a pilot that claimed to save workers 43 minutes daily on administrative tasks. The £120 million deployment represents the largest healthcare AI implementation globally, but questions remain about whether the time savings will hold at scale across one of the world's most complex health systems.

Technology3 sources

NHS England deploys Microsoft Copilot to 505,000 staff in largest healthcare AI rollout

Technology3 sources

New AI technology speeds eye disease diagnosis and predicts heart attack, stroke risks from retinal scans

Researchers at Washington University School of Medicine developed OCTCube-M, an AI system that analyzes 3D eye scans to detect retinal diseases more accurately than older models. The technology identified 43 to 60 additional cases per 1,000 individuals and can predict broader health risks including heart attack, stroke, and kidney failure based solely on retinal imaging.

Health2 sources

New AI technology speeds eye disease diagnosis and predicts heart attack, stroke risks from retinal scans

Health2 sources

New AI tool achieves near-perfect accuracy in distinguishing Alzheimer's from Lewy body dementia

University of Florida researchers developed AIDD, an AI-powered tool that combines brain scans with machine learning to distinguish between Alzheimer's disease and dementia with Lewy bodies with near-perfect accuracy. The breakthrough addresses a critical problem: up to 50% of Lewy body dementia patients are misdiagnosed as having Alzheimer's, leading to treatments that can worsen symptoms.

Health2 sources

New AI tool achieves near-perfect accuracy in distinguishing Alzheimer's from Lewy body dementia

Health2 sources

Sanofi and Owkin deepen AI partnership with five-year K Pro license for drug development

Sanofi and Owkin have expanded their multi-year partnership to co-develop AI-driven biopharma agents through a five-year license for K Pro, Owkin's AI Scientist platform. The collaboration builds on their 90 million euro strategic partnership that began in 2021, focusing on oncology and immunology research. The new initiative aims to automate complex pharmaceutical research tasks across the drug development pipeline.

Technology2 sources

Sanofi and Owkin deepen AI partnership with five-year K Pro license for drug development

Technology2 sources

AI-designed vaccine passes first human trial, offering broad protection against coronaviruses

Researchers at the University of Cambridge successfully tested the world's first AI-designed vaccine in humans. The trial involved 39 volunteers and targeted multiple coronaviruses, including COVID-19 and SARS. The vaccine uses an AI-designed super-antigen that could provide lasting protection against entire virus families, even as they mutate, potentially transforming how we prepare for future pandemics.

Health11 sources

AI-designed vaccine passes first human trial, offering broad protection against coronaviruses

Health11 sources

AI Diagnosis Outperforms Emergency Room Doctors in Harvard Study, Raises Questions on Patient Care

A Harvard Medical School study published in Science reveals that OpenAI's o1 model achieved 67% diagnostic accuracy at emergency room triage, outperforming two attending physicians who scored 55% and 50%. The research tested AI against doctors using real patient data from Beth Israel Deaconess Medical Center, with blinded reviewers unable to distinguish AI output from human diagnoses. While the findings demonstrate AI's potential as a diagnostic tool, researchers emphasize the urgent need for clinical trials and accountability frameworks before deployment in actual patient care settings.

Science16 sources

AI Diagnosis Outperforms Emergency Room Doctors in Harvard Study, Raises Questions on Patient Care

Science16 sources

Medical AI startup Aidoc raises $150M from Goldman Sachs and Nvidia, eyes IPO within five years

Medical AI provider Aidoc secured $150 million in a Goldman Sachs-led funding round, with participation from Nvidia's NVentures, General Catalyst, and SoftBank Investment Advisors. The company, which has now raised $520 million total, plans to use proceeds for regulatory approvals and building comprehensive AI models while targeting an IPO in three to five years.

Startups2 sources

Medical AI startup Aidoc raises $150M from Goldman Sachs and Nvidia, eyes IPO within five years

Startups2 sources

FDA deploys AI to monitor clinical trials in real time, cutting drug development by up to 40%

The FDA announced its first real-time clinical trials using AI to track patient safety and effectiveness data as it's collected. The initiative could reduce drug development time by 20-40% by eliminating administrative delays that currently consume 45% of the timeline between Phase 1 trials and FDA submissions.

Policy2 sources

FDA deploys AI to monitor clinical trials in real time, cutting drug development by up to 40%

Policy2 sources

Prev 1 234…10 Next